Research article · Mar 2013
EditorialPublished Feb 2013
Imaging Biomarkers in Drug Development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Imaging Biomarkers in Drug Development The price tag of drug development has steadily increased over the years with it now costing an average of $1.3 billion and ten years to bring a new drug to market. These staggering numbers play a significant role in the rising price of drugs. For example, the anti-cancer drug, bevacizumab costs about $50,000 for one year’s treatment. This contributes to the unsustainable rise in healthcare expense and leads to increasing pressure to reduce the costs of drug development.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Biomarkers in Drug Development.
Other · Feb 2013
Editor & Editorial Board Members
Editorial · Feb 2013
Nanotechnology for Circulating Tumor Biomarker Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomarkers in Drug Development
- SubjectPathology & Lab Medicine
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sheela Agarwal”
- BylineArticles whose byline prints “Janet C. Miller”
- BylineArticles whose byline prints “Sanjay Saini”
